Ed Schuuring

32PUBLICATIONS
116CO-AUTHORS
Predictive and prognostic markersMolecular targetsGene expression (incl. microarray and other genome-wide approaches)Medical biotechnology diagnostics (incl. biosensors)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|May 22, 2026
PAX1 and ZNF582 methylation as a triage strategy in cytological and hrHPV-positive scrapings in both Chinese and Dutch cohorts.

|Aug 28, 2025
Cell-Free DNA Based Next-Generation Sequencing Does Not Differentiate Between Oligoprogression and Systemic Progression in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors-An Explorative Study.

Pim Rozendal, Hanneke Kievit, Paul van der Leest

|Jun 13, 2025
The Association Between Clinical Outcome and Expression of DNMT1, 3A, and 3B in Locally Advanced Laryngeal Carcinomas Treated by Definitive Radiotherapy.

Karlijn van den Bovenkamp, Gyorgy B Halmos, Lorian Slagter-Menkema

|Mar 07, 2025
Costs of biomarker testing in advanced non-small cell lung cancer: a global study comparing next-generation sequencing and single-gene testing.

Umberto Malapelle, Chien-Chin Chen, Enrique de Álava

|Feb 26, 2025
Molecular Testing as Triage in Cervical Cancer Screening: Economic Evaluation Using Headroom Analysis.

Kelly M Castañeda, Karin M Vermeulen, Antoinette D I van Asselt

|Jan 24, 2025
Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-grade Cervical Intraepithelial Neoplasia: A Phase II Trial.

Anneke L Eerkens, Martha D Esajas, Koen Brummel

Pageof 6

Frequent Collaborators

8 joint publications

Harry Jm Groen

7 joint publications

Paul van der Leest

5 joint publications

Thijo Jeroen N Hiltermann

5 joint publications

Léon C van Kempen